Letter to the editor: Electronic RUCAM: Major pitfalls call for caution and proper validation
- PMID: 35243675
- DOI: 10.1002/hep.32440
Letter to the editor: Electronic RUCAM: Major pitfalls call for caution and proper validation
Comment on
-
Letter to the editor: A revised electronic version of RUCAM for the diagnosis of drug-induced liver injury.Hepatology. 2022 Oct;76(4):E71-E72. doi: 10.1002/hep.32522. Epub 2022 Jun 10. Hepatology. 2022. PMID: 35451140 No abstract available.
References
REFERENCES
-
- Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, et al. A revised electronic version of RUCAM for the diagnosis of drug induced liver injury. Hepatology. 2022;76:18-31.
-
- Teschke R, Danan G. Worldwide use of RUCAM for causality assessment in 81,856 idiosyncratic DILI and 14,029 HILI cases published 1993-mid 2020: a comprehensive analysis. Medicines. 2020;7:62.
-
- Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs. II: An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol. 1993;46:1331-6.
-
- Björnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: critical assessment based on published case reports. Hepatology. 2016;63:590-603.
-
- Ke L, Lu C, Shen R, Lu T, Ma B, Hua Y, et al. Knowledge mapping of drug-induced liver injury: a scientometric investigation (2010-2019). Front Pharmacol. 2020;11:842.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
